Van Strum & Towne’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
715
-15
| -2% | -$6.08K | 0.09% | 96 |
|
|
2025
Q1 | $363K | Sell |
730
-15
| -2% | -$7.46K | 0.12% | 86 |
|
|
2024
Q4 | $388K | Hold |
745
| – | – | 0.14% | 76 |
|
|
2024
Q3 | $461K | Hold |
745
| – | – | 0.16% | 70 |
|
|
2024
Q2 | $412K | Hold |
745
| – | – | 0.15% | 71 |
|
|
2024
Q1 | $433K | Hold |
745
| – | – | 0.16% | 71 |
|
|
2023
Q4 | $395K | Sell |
745
-20
| -3% | -$10.6K | 0.16% | 71 |
|
|
2023
Q3 | $387K | Hold |
765
| – | – | 0.16% | 67 |
|
|
2023
Q2 | $399K | Hold |
765
| – | – | 0.17% | 67 |
|
|
2023
Q1 | $441K | Hold |
765
| – | – | 0.19% | 60 |
|
|
2022
Q4 | $421K | Hold |
765
| – | – | 0.18% | 60 |
|
|
2022
Q3 | $388K | Hold |
765
| – | – | 0.18% | 61 |
|
|
2022
Q2 | $416K | Hold |
765
| – | – | 0.18% | 63 |
|
|
2022
Q1 | $452K | Hold |
765
| – | – | 0.17% | 64 |
|
|
2021
Q4 | $510K | Sell |
765
-30
| -4% | -$20K | 0.18% | 66 |
|
|
2021
Q3 | $454K | Hold |
795
| – | – | 0.18% | 67 |
|
|
2021
Q2 | $401K | Buy |
795
+100
| +14% | +$50.4K | 0.19% | 67 |
|
|
2021
Q1 | $317K | Hold |
695
| – | – | 0.16% | 73 |
|
|
2020
Q4 | $324K | Hold |
695
| – | – | 0.18% | 70 |
|
|
2020
Q3 | $307K | Hold |
695
| – | – | 0.2% | 62 |
|
|
2020
Q2 | $252K | Buy |
+695
| New | +$252K | 0.18% | 65 |
|
|
2020
Q1 | – | Sell |
-695
| Closed | -$226K | – | 78 |
|
|
2019
Q4 | $226K | Sell |
695
-25
| -3% | -$8.13K | 0.14% | 71 |
|
|
2019
Q3 | $210K | Hold |
720
| – | – | 0.14% | 73 |
|
|
2019
Q2 | $211K | Buy |
+720
| New | +$211K | 0.15% | 68 |
|